Cerevel Therapeutics Holdings, Inc.

VOLORIDGE INVESTMENT MANAGEMENT, LLC

Report date

3/31/2024

Quarter

2024 Q1

Filed

5/15/2024

Shares

564,044

Value ($000)

23,842

Weight

0.1%

2021 Q3 - 2024 Q1 (4 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q1	5/15/2024	23,842	0.1%	564,044	3/31/2024
2023 Q4	2/14/2024	38,161	0.2%	900,024	12/31/2023
2021 Q4	2/14/2022	1,566	0.0%	48,289	12/31/2021
2021 Q3	11/15/2021	2,720	0.0%	92,207	9/30/2021